IRF4 and hematologic disorder: Likewise, blockade of STAT3 with small-molecule inhibitors such as JQ1 diminishes IRF4-associated transcriptional modules in lymphocytes and myeloid cells [224], while BET bromodomain inhibitors such as I-BET762 downregulate IRF4 expression and IRF4-driven inflammatory genes in hematologic malignancies [225].